Roof Eidam & Maycock Amgen Inc Transaction History

Roof Eidam & Maycock

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $1.41 Million - $1.86 Million	-7,710 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $946 - $1,216	5 Added 0.06%	7,710 $1.86 Million
Q3 2019 Nov 05, 2019	SELL	$174.11 - $208.62 $1,741 - $2,086	-10 Reduced 0.13%	7,705 $1.49 Million
Q2 2019 Jul 22, 2019	SELL	$166.7 - $195.41 $139,194 - $163,167	-835 Reduced 9.77%	7,715 $1.42 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $1.55 Million - $1.74 Million	8,550 New	8,550 $1.62 Million

Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $871,717 - $1.02 Million	-5,145 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $8,439 - $9,429	50 Added 0.98%	5,145 $895,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $852,342 - $973,145	5,095	5,095 $950,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Roof Eidam & Maycock, based on Form 13F filings with the SEC.

Stay updated on Roof Eidam & Maycock with notifications on news.